Skip to content
10-Q

Quarterly Report

Medpace Holdings, Inc. MEDP

0001668397-26-000019

← back to feed
Filed
Apr 23, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · Apr 17, 2026 28.56M sh
Shares Diluted Q1 2026 · Mar 31, 2026 28.96M sh
Shares Diluted Q1 2026 · Mar 31, 2025 31.2M sh
Stock Repurchased Q1 2026 · Mar 31, 2026 $0
Stock Repurchased Q1 2026 · Mar 31, 2025 $371.9M
Capex Q1 2026 · Mar 31, 2026 $6.81M
Capex Q1 2026 · Mar 31, 2025 $9.99M
Operating Cash Flow Q1 2026 · Mar 31, 2026 $151.79M
Operating Cash Flow Q1 2026 · Mar 31, 2025 $125.84M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $652.68M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $497.05M
Stockholders Equity Q1 2026 · Mar 31, 2026 $598.31M
Stockholders Equity Q1 2026 · Dec 31, 2025 $459.07M
Stockholders Equity Q1 2026 · Mar 31, 2025 $593.61M
Stockholders Equity Q1 2026 · Dec 31, 2024 $825.55M
Current Liabilities Q1 2026 · Mar 31, 2026 $1.35B
Current Liabilities Q1 2026 · Dec 31, 2025 $1.34B
Total Liabilities Q1 2026 · Mar 31, 2026 $1.53B
Total Liabilities Q1 2026 · Dec 31, 2025 $1.52B
Current Assets Q1 2026 · Mar 31, 2026 $1.14B
Current Assets Q1 2026 · Dec 31, 2025 $989.62M
Total Assets Q1 2026 · Mar 31, 2026 $2.13B
Total Assets Q1 2026 · Dec 31, 2025 $1.98B
Eps Diluted Q1 2026 · Mar 31, 2026 $4.28
Eps Diluted Q1 2026 · Mar 31, 2025 $3.67
Eps Basic Q1 2026 · Mar 31, 2026 $4.35
Eps Basic Q1 2026 · Mar 31, 2025 $3.77
Sga Expense Q1 2026 · Mar 31, 2026 $47.92M
Sga Expense Q1 2026 · Mar 31, 2025 $57.9M
Net Income Q1 2026 · Mar 31, 2026 $123.87M
Net Income Q1 2026 · Mar 31, 2025 $114.6M
Operating Income Q1 2026 · Mar 31, 2026 $141.5M
Operating Income Q1 2026 · Mar 31, 2025 $113.52M
Revenue Q1 2026 · Mar 31, 2026 $706.6M
Revenue Q1 2026 · Mar 31, 2025 $558.57M